Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.

Fuller CD, Wang SJ, Choi M, Czito BG, Cornell J, Welzel TM, McGlynn KA, Luh JY, Thomas CR Jr.

Cancer. 2009 Nov 15;115(22):5175-83. doi: 10.1002/cncr.24572.

2.

Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.

Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, Crane CH, Talamonti MS, Munoz LL, Small W Jr.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):189-98. doi: 10.1016/j.ijrobp.2010.05.001. Epub 2010 Oct 23.

PMID:
20971573
3.

Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas.

Shinohara ET, Mitra N, Guo M, Metz JM.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1191-8. doi: 10.1016/j.ijrobp.2008.09.017. Epub 2009 Feb 7.

PMID:
19201549
4.

Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma.

Shinohara ET, Mitra N, Guo M, Metz JM.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1495-501. doi: 10.1016/j.ijrobp.2008.03.018. Epub 2008 May 28.

PMID:
18472359
5.

External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.

Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, Ben-Josef E.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):772-9.

PMID:
17011452
6.

Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.

Bonet Beltrán M, Roth AD, Mentha G, Allal AS.

BMC Cancer. 2011 Jun 24;11:267. doi: 10.1186/1471-2407-11-267.

7.

Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.

Alden ME, Waterman FM, Topham AK, Barbot DJ, Shapiro MJ, Mohiuddin M.

Radiology. 1995 Nov;197(2):511-6.

PMID:
7480704
8.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
9.

Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.

McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA.

Am J Surg. 1997 Dec;174(6):605-8; discussion 608-9.

PMID:
9409582
10.

Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis.

Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD.

J Gastrointest Surg. 2007 Nov;11(11):1488-96; discussion 1496-7. Epub 2007 Sep 5.

PMID:
17805937
11.

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemore KD, Cameron JL.

Ann Surg. 1995 Jun;221(6):788-97; discussion 797-8.

12.

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.

Cancer. 2012 Oct 1;118(19):4737-47. doi: 10.1002/cncr.27492. Epub 2012 Mar 13.

13.

Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.

Kaiser GM, Frühauf NR, Lang H, Sauerwein W, Sotiropoulos GC, Zöpf T, Grabellus F, Wittig A, Oldhafer KJ, Malagó M, Broelsch CE.

Hepatogastroenterology. 2008 Nov-Dec;55(88):1951-4.

PMID:
19260456
14.

Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.

Matsuda T, Fujita H, Harada N, Kunimoto Y, Tanaka T, Kimura T, Kitaoka H, Asano E, Hosono M, Hayashi T, Ogino K.

Am J Clin Oncol. 2013 Oct;36(5):461-5. doi: 10.1097/COC.0b013e31825494ab.

PMID:
22706178
15.

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y.

Cancer. 2003 Oct 15;98(8):1689-700.

16.

Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.

Brunner TB, Eccles CL.

Strahlenther Onkol. 2010 Dec;186(12):672-80. doi: 10.1007/s00066-010-2161-y. Epub 2010 Nov 30. Review.

PMID:
21136029
17.

Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.

Sagawa N, Kondo S, Morikawa T, Okushiba S, Katoh H.

Surg Today. 2005;35(7):548-52.

PMID:
15976951
18.
19.

An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection.

Hernandez J, Cowgill SM, Al-Saadi S, Villadolid D, Ross S, Kraemer E, Shapiro M, Mullinax J, Cooper J, Goldin S, Zervos E, Rosemurgy A.

Ann Surg Oncol. 2008 Mar;15(3):807-14. doi: 10.1245/s10434-007-9756-2. Epub 2008 Jan 8.

PMID:
18181000
20.

Brachytherapy in the treatment of cholangiocarcinoma.

Shinohara ET, Guo M, Mitra N, Metz JM.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):722-8. doi: 10.1016/j.ijrobp.2009.08.070. Epub 2010 Mar 6.

PMID:
20207503
Items per page

Supplemental Content

Write to the Help Desk